Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home

International Journal of Medical Sciences And Clinical Research

Peer Reviewed | Open Access | E-ISSN: 2771-2265
Published Article

Diagnostic Accuracy of the FINDRISC Score for Detecting Undiagnosed Type 2 Diabetes Mellitus and Prediabetes

Diagnostic Accuracy of the FINDRISC Score for Detecting Undiagnosed Type 2 Diabetes Mellitus and Prediabetes

  • Mohanad Qasim Mahfoodh Abdullah
    Family Medicine Specialist, C.A.B.S. (Family Medicine), Ministry of Health- Karbala Health Directorate, Iraq
  • Sarah Sabah Hasan Alshami
    Family Medicine Specialist, C.A.B.S. (Family Medicine), Ministry of Health- Karbala Health Directorate, Iraq
  • Nidhal Awad Obaid Alibraheemi
    Family Medicine Specialist, C.A.B.S. (Family Medicine), Ministry of Health- Karbala Health Directorate, Iraq

Background: Type 2 diabetes mellitus represents a major global public health challenge, particularly in low- and middle-income countries, with a large proportion of cases remaining undiagnosed. Early identification of high-risk individuals is essential to prevent disease progression and complications. The Finnish Diabetes Risk Score is a simple, non-invasive screening tool that has been widely used to estimate the risk and diagnosis of type 2 diabetes mellitus and may offer a practical alternative to laboratory-based screening in resource-limited settings.

Aim of the study: To assess the ability of the Finnish Diabetes Risk Score to identify undiagnosed type 2 diabetes mellitus and prediabetes among Iraqi adults.

Patients and methods: Cross-sectional study was conducted at primary health care centers in Karbala Health Directorate/ Iraq from February 2025 to February 2026 and included 200 adult participants without previously diagnosed diabetes or prediabetes. Data collection included anthropometric measurements, and clinical history. The Finnish Diabetes Risk Score was calculated for each participant. Laboratory assessment included fasting blood sugar and glycated hemoglobin. analysis was used to evaluate diagnostic accuracy.

Results: According to laboratory findings, 26 participants (13%) were diabetic, 35 (17.5%) were prediabetic, and 139 (69.5%) were non-diabetic. The mean fasting blood sugar was 180.7 ± 63.1 mg/dL, and the mean HbA1c was 7.5 ± 4.2%. The mean FINDRISC score was 13.8 ± 4.6 (range: 4–24), with 71 participants (35.5%) classified as high risk (≥15 points), 14 (7.0%) as moderate risk (12–14 points), and 115 (57.5%) as low risk (<12 points). FINDRISC demonstrated good diagnostic accuracy for detecting diabetes, with an area under the curve (AUC) of 0.86 at a cutoff ≥15, yielding a sensitivity of 82.2%, specificity of 71.3%, positive predictive value of 77.5%, negative predictive value of 76.4%, and overall accuracy of 77.6%. For prediabetes, the AUC was 0.78 at a cutoff ≥12, with sensitivity of 74.6%, specificity of 64.5%, and accuracy of 69.2%. Significant associations with glycemic status were observed for age (p = 0.021), body mass index (p = 0.033), central obesity (p = 0.031), physical inactivity (p = 0.041), low fruit and vegetable intake (p = 0.028), hypertension (p = 0.009), family history of diabetes (p = 0.022), and history of hyperglycemia (p < 0.001), while gender was not significantly associated (p = 0.063).

Conclusions: The Finnish Diabetes Risk Score showed good diagnostic accuracy in identifying undiagnosed type 2 diabetes mellitus and acceptable accuracy for prediabetes among Iraqi adults.

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of illness in type 2 diabetes mellitus. Journal of managed care & specialty pharmacy. 2018 Sep;24(9-a Suppl):S5-13.

Ye J, Wu Y, Yang S, Zhu D, Chen F, Chen J, Ji X, Hou K. The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Frontiers in endocrinology. 2023 Jul 14;14:1192629.

Moradinazar M, Babakhani M, Rostami R, Shakiba M, Moradi A, Shakiba E. Epidemiological status of type 2 diabetes mellitus in the Middle East and North Africa, 1990-2019. Eastern Mediterranean Health Journal. 2022 Jul 1;28(7).

Mansour AA, Alibrahim NT, Alidrisi HA, Alhamza AH, Almomin AM, Zaboon IA, Kadhim MB, Hussein RN, Nwayyir HA, Mohammed AG, Al-Waeli DK. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 May 1;14(3):265-72.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019 Nov 1;157:107843.

Dugani SB, Mielke MM, Vella A. Burden and management of type 2 diabetes in rural United States. Diabetes/metabolism research and reviews. 2021 Jul;37(5):e3410.

Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R. Screening for type 2 diabetes mellitus: a systematic review for the US Preventive Services Task Force. Annals of internal medicine. 2015 Jun 2;162(11):765-76.

DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC. Type 2 diabetes mellitus. Nature reviews Disease primers. 2015 Jul 23;1(1):1-22.

Salinero-Fort MA, Burgos-Lunar C, Lahoz C, Mostaza JM, Abánades-Herranz JC, Laguna-Cuesta F, Estirado-de Cabo E, García-Iglesias F, González-Alegre T, Fernández-Puntero B, Montesano-Sánchez L. Performance of the finnish diabetes risk score and a simplified finnish diabetes risk score in a community-based, cross-sectional programme for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in madrid, Spain: The SPREDIA-2 study. Plos one. 2016 Jul 21;11(7):e0158489.

Janghorbani M, Adineh H, Amini M. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome. The review of diabetic studies: RDS. 2014 Feb 10;10(4):283.

Jin S, Chen Q, Han X, Liu Y, Cai M, Yao Z, Lu H. Comparison of the Finnish Diabetes Risk Score model with the metabolic syndrome in a Shanghai population. Frontiers in Endocrinology. 2022 Feb 22;13:725314.

Meijnikman AS, De Block CE, Verrijken A, Mertens I, Van Gaal LF. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome. Diabetology & metabolic syndrome. 2018 Mar 1;10(1):12.

Agarwal G, Guingona MM, Gaber J, Angeles R, Rao S, Cristobal F. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population. BMC Public Health. 2019 Aug 27;19(1):1169.

Cahyaningsih I, Rokhman MR, Sudikno, Postma MJ, van der Schans J. Accuracy of the Modified Finnish Diabetes Risk Score (Modified FINDRISC) for detecting metabolic syndrome: Findings from the Indonesian national health survey. Plos one. 2025 Feb 12;20(2):e0314824.

Arnardóttir E, Sigurðardóttir ÁK, Graue M, Kolltveit BC, Skinner T. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care. BMC Public Health. 2023 Jan 31;23(1):211.

De Tata V. Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms. Frontiers in endocrinology. 2014 Sep 3;5:138.

Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine reviews. 2016 Jun 1;37(3):278-316.

Muraszewski Ł, Muraszewska E, Kwitowska P, Pyjecka M, Ubysz E, Król A, Lewandowska E, Łuczyński C, Paczkowski M, Wręczycki M. The Role of Physical Activity in Improving Insulin Sensitivity: A Narrative Review. Quality in Sport. 2026 Mar 17;52:69768-.

Safabakhsh M, Koohdani F, Bagheri F, Siassi F, Khajehnasiri F, Sotoudeh G. Fruit and vegetable intake and pre-diabetes: a case–control study. European journal of nutrition. 2018 Dec;57(8):2953-62.

Alharithy MK, Alobaylan MM, Alsugair ZO, Alswat KA. Impact of family history of diabetes on diabetes control and complications. Endocrine Practice. 2018 Sep 1;24(9):773-9.